Average Co-Inventor Count = 3.88
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ventirx Pharmaceuticals, Inc. (9 from 10 patents)
2. Corixa Corporation (8 from 247 patents)
3. Array Biopharma Inc. (6 from 329 patents)
4. University of Pennsylvania (2,597 patents)
17 patents:
1. 10981978 - Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
2. 10457722 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
3. 10016440 - Methods of enhancing antibody-dependent cellular cytotoxicity
4. 10011650 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
5. 9868779 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
6. 9718796 - Substituted benzoazepines as toll-like receptor modulators
7. 9655904 - Substituted benzoazepines as toll-like receptor modulators
8. 9290543 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
9. 9242964 - Substituted benzoazepines as toll-like receptor modulators
10. 9216192 - Toll-like receptor agonist formulations and their use
11. 9175046 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
12. 9126940 - Substituted benzoazepines as toll-like receptor modulators
13. 8691809 - Substituted benzoazepines as toll-like receptor modulators
14. 8524702 - Substituted benzoazepines as toll-like receptor modulators
15. 8318901 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease